MedTrace Logo

Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate

NCT02243137 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-09-17

No results posted yet for this study

Summary

This is a phase I clinical trial in healthy volunteers comparing the effect of lysine acetylsalicylate or aspirin on platelet function.

Conditions

  • Adverse Effect of Antithrombotic Drugs

Interventions

DRUG

acetylsalicylic acid

Administration: one dose of Acetylsalicylic Acid (300mg)

DRUG

prasugrel

Administration: one loading dose (60mg)

DRUG

lysine acetylsalicylate

Administration: one dose (450mg iv)

Sponsors & Collaborators

  • St Carlos Hospital, Madrid, Spain

    collaborator OTHER

  • David Vivas

    lead OTHER

Principal Investigators

  • David Vivas, MD, PhD · San Carlos University Hospital, Madrid Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02243137 on ClinicalTrials.gov